369 related articles for article (PubMed ID: 28108297)
1. The Leukotriene B
Sezin T; Krajewski M; Wutkowski A; Mousavi S; Chakievska L; Bieber K; Ludwig RJ; Dahlke M; Rades D; Schulze FS; Schmidt E; Kalies K; Gupta Y; Schilf P; Ibrahim SM; König P; Schwudke D; Zillikens D; Sadik CD
J Invest Dermatol; 2017 May; 137(5):1104-1113. PubMed ID: 28108297
[TBL] [Abstract][Full Text] [Related]
2. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
3. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease.
Sezin T; Murthy S; Attah C; Seutter M; Holtsche MM; Hammers CM; Schmidt E; Meshrkey F; Mousavi S; Zillikens D; Nunn MA; Sadik CD
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391346
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
[TBL] [Abstract][Full Text] [Related]
6. The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita.
Németh T; Virtic O; Sitaru C; Mócsai A
J Invest Dermatol; 2017 Oct; 137(10):2131-2139. PubMed ID: 28576735
[TBL] [Abstract][Full Text] [Related]
7. 12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation.
Sezin T; Ferreirós N; Jennrich M; Ochirbold K; Seutter M; Attah C; Mousavi S; Zillikens D; Geisslinger G; Sadik CD
J Autoimmun; 2020 Dec; 115():102528. PubMed ID: 32768245
[TBL] [Abstract][Full Text] [Related]
8. Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.
Margaroli C; Bradley B; Thompson C; Brown MR; Giacalone VD; Bhatt L; Stoff B; Ahuja S; Springman E; Tirouvanziam R; Feldman RJ
Exp Dermatol; 2020 Dec; 29(12):1191-1198. PubMed ID: 33047366
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.
Gardner KM; Crawford RI
J Cutan Med Surg; 2018; 22(1):22-24. PubMed ID: 28719980
[TBL] [Abstract][Full Text] [Related]
10. Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
Hellberg L; Samavedam UKSRL; Holdorf K; Hänsel M; Recke A; Beckmann T; Steinhorst K; Boehncke WH; Kirchner T; Möckel N; Solbach W; Zillikens D; Schmidt E; Ludwig RJ; Laskay T
J Invest Dermatol; 2013 Oct; 133(10):2390-2399. PubMed ID: 23448878
[TBL] [Abstract][Full Text] [Related]
11. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis.
Kim ND; Chou RC; Seung E; Tager AM; Luster AD
J Exp Med; 2006 Apr; 203(4):829-35. PubMed ID: 16567386
[TBL] [Abstract][Full Text] [Related]
12. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid.
Akbarzadeh R; Yu X; Vogl T; Ludwig RJ; Schmidt E; Zillikens D; Petersen F
J Dermatol Sci; 2016 Mar; 81(3):165-72. PubMed ID: 26692467
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of bullous pemphigoid from epidermolysis bullosa acquisita on frozen skin biopsies.
Valeski JE; Kumar V; Beutner EH; Cartone C; Kasprzyk K
Int J Dermatol; 1992 Jan; 31(1):37-41. PubMed ID: 1737687
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Glucose Metabolism Abrogates the Effector Phase of Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita.
Schilf P; Schmitz M; Derenda-Hell A; Thieme M; Bremer T; Vaeth M; Zillikens D; Sadik CD
J Invest Dermatol; 2021 Jul; 141(7):1646-1655.e3. PubMed ID: 33609554
[TBL] [Abstract][Full Text] [Related]
16. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation.
Oyoshi MK; He R; Li Y; Mondal S; Yoon J; Afshar R; Chen M; Lee DM; Luo HR; Luster AD; Cho JS; Miller LS; Larson A; Murphy GF; Geha RS
Immunity; 2012 Oct; 37(4):747-58. PubMed ID: 23063331
[TBL] [Abstract][Full Text] [Related]
18. Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases.
Murthy S; Schilf P; Patzelt S; Thieme M; Becker M; Kröger L; Bremer T; Derenda-Hell A; Knebel L; Fagiani F; Ibrahim SM; Schmidt E; Zillikens D; Sadik CD
J Invest Dermatol; 2021 Nov; 141(11):2587-2595.e2. PubMed ID: 34033839
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of immunoreactive leukotriene B4 in blister fluids of bullous pemphigoid patients and effects of a selective 5-lipoxygenase inhibitor on experimental skin lesions.
Kawana S; Ueno A; Nishiyama S
Acta Derm Venereol; 1990; 70(4):281-5. PubMed ID: 1977249
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
